Neuberger Berman Group
INO icon

Neuberger Berman Group’s Inovio Pharmaceuticals INO Stock Holding History

Neuberger Berman Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,407
Closed -$156K – 1789
2021
Q1 		$156K Hold
1,407
– – ﹤0.01% 1723
2020
Q4 		$150K Hold
1,407
– – ﹤0.01% 1649
2020
Q3 		$196K Sell
1,407
-1,363
-49% -$284K ﹤0.01% 1565
2020
Q2 		$896K Sell
2,770
-1,396
-34% -$224K ﹤0.01% 1165
2020
Q1 		$372K Sell
4,166
-533
-11% -$32.9K ﹤0.01% 1304
2019
Q4 		$186K Hold
4,699
– – ﹤0.01% 1492
2019
Q3 		$116K Buy
4,699
+4
+0.1% +$122 ﹤0.01% 1503
2019
Q2 		$166K Buy
4,695
+2,562
+120% +$102K ﹤0.01% 1508
2019
Q1 		$95K Hold
2,133
– – ﹤0.01% 1491
2018
Q4 		$102K Buy
+2,133
New +$130K ﹤0.01% 1539
2018
Q3 		– Sell
-2,893
Closed -$136K – 1657
2018
Q2 		$136K Buy
2,893
+50
+2% +$2.76K ﹤0.01% 1673
2018
Q1 		$161K Hold
2,843
– – ﹤0.01% 1635
2017
Q4 		$141K Buy
2,843
+1,329
+88% +$82.4K ﹤0.01% 1713
2017
Q3 		$115K Buy
+1,514
New +$113K ﹤0.01% 1570

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Neuberger Berman Group's INO Position: Q2 2021 in Review

Neuberger Berman Group sold out of Inovio Pharmaceuticals (INO) in Q2 2021, closing a stake of 1,407 shares — an estimated $156K sold.

Neuberger Berman Group first reported a position in INO in Q3 2017 and held it in 14 quarters. The position peaked at $896K in Q2 2020. 211 funds tracked by Wall St. Rank hold INO as of Q2 2021.

  • Neuberger Berman Group reported no remaining Inovio Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Neuberger Berman Group sold 1,407 Inovio Pharmaceuticals shares in Q2 2021, an estimated $156K.
  • Neuberger Berman Group first reported a position in Inovio Pharmaceuticals in Q3 2017 and held it in 14 quarters.
  • Neuberger Berman Group's Inovio Pharmaceuticals position peaked at $896K in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2021.

Based on Neuberger Berman Group's 13F filing for Q2 2021, filed 13 Aug 2021.